Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH.
Welch RD, Billon C, Losby M, Bedia-Diaz G, Fang Y, Avdagic A, Elgendy B, Burris TP, Griffett K. Welch RD, et al. Among authors: billon c. Metabolites. 2022 Mar 11;12(3):238. doi: 10.3390/metabo12030238. Metabolites. 2022. PMID: 35323681 Free PMC article. Review.
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.
Billon C, Sitaula S, Banerjee S, Welch R, Elgendy B, Hegazy L, Oh TG, Kazantzis M, Chatterjee A, Chrivia J, Hayes ME, Xu W, Hamilton A, Huss JM, Zhang L, Walker JK, Downes M, Evans RM, Burris TP. Billon C, et al. ACS Chem Biol. 2023 Apr 21;18(4):756-771. doi: 10.1021/acschembio.2c00720. Epub 2023 Mar 29. ACS Chem Biol. 2023. PMID: 36988910
A Synthetic ERR Agonist Alleviates Metabolic Syndrome.
Billon C, Schoepke E, Avdagic A, Chatterjee A, Butler AA, Elgendy B, Walker JK, Burris TP. Billon C, et al. J Pharmacol Exp Ther. 2024 Jan 17;388(2):232-240. doi: 10.1124/jpet.123.001733. J Pharmacol Exp Ther. 2024. PMID: 37739806
The Orphan Nuclear Receptor TLX Is a Receptor for Synthetic and Natural Retinoids.
Griffett K, Bedia-Diaz G, Hegazy L, de Vera IMS, Wanninayake US, Billon C, Koelblen T, Wilhelm ML, Burris TP. Griffett K, et al. Among authors: billon c. Cell Chem Biol. 2020 Oct 15;27(10):1272-1284.e4. doi: 10.1016/j.chembiol.2020.07.013. Epub 2020 Aug 6. Cell Chem Biol. 2020. PMID: 32763139 Free article.
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.
Burris TP, de Vera IMS, Cote I, Flaveny CA, Wanninayake US, Chatterjee A, Walker JK, Steinauer N, Zhang J, Coons LA, Korach KS, Cain DW, Hollenberg AN, Webb P, Forrest D, Jetten AM, Edwards DP, Grimm SL, Hartig S, Lange CA, Richer JK, Sartorius CA, Tetel M, Billon C, Elgendy B, Hegazy L, Griffett K, Peinetti N, Burnstein KL, Hughes TS, Sitaula S, Stayrook KR, Culver A, Murray MH, Finck BN, Cidlowski JA. Burris TP, et al. Among authors: billon c. Pharmacol Rev. 2023 Nov;75(6):1233-1318. doi: 10.1124/pharmrev.121.000436. Epub 2023 Aug 16. Pharmacol Rev. 2023. PMID: 37586884 Free PMC article. Review.
RORγ regulates the NLRP3 inflammasome.
Billon C, Murray MH, Avdagic A, Burris TP. Billon C, et al. J Biol Chem. 2019 Jan 4;294(1):10-19. doi: 10.1074/jbc.AC118.002127. Epub 2018 Nov 19. J Biol Chem. 2019. PMID: 30455347 Free PMC article.
Suppression of atherosclerosis by synthetic REV-ERB agonist.
Sitaula S, Billon C, Kamenecka TM, Solt LA, Burris TP. Sitaula S, et al. Among authors: billon c. Biochem Biophys Res Commun. 2015 May 8;460(3):566-71. doi: 10.1016/j.bbrc.2015.03.070. Epub 2015 Mar 20. Biochem Biophys Res Commun. 2015. PMID: 25800870 Free PMC article.
70 results